全球胰岛素输送设备市场：依产品、最终用户、地区、机会、预测，2017-2031年

全球胰岛素输送设备市场规模将从2023年的 221.2亿美元成长到2031年的 400.4亿美元，2024-2031年预测期间年复合成长率为 7.70%。糖尿病盛行率的上升、新产品的推出、政府措施的增加以及市场主要参与者的联盟支持了市场的成长。胰岛素输送设备，包括胰岛素笔、帮浦、针头和注射器，用于向糖尿病患者註射胰岛素，帮助他们维持最佳血糖值。

各种医疗保健和政府机构努力提高人们对糖尿病和可用于有效管理血糖值的各种设备的认识。这种日益增强的意识鼓励个人定期检查并采用有效的胰岛素管理解决方案，推动市场扩张。也鼓励医疗保健和医疗器材製造商透过研发和併购获得先进的胰岛素输送解决方案。

全球糖尿病患者数量的不断增加推动全球胰岛素输送设备市场规模的扩大。根据世界卫生组织（WHO）估计，全球约有 4.22亿人患有糖尿病。糖尿病患者数量的增加推动了对高效胰岛素输送设备的需求，而加强公众对该疾病认识的举措不断增加，也有助于提高糖尿病筛检率。有效管理胰岛素水平对于管理糖尿病非常重要，因为医疗保健提供者确保提供各种胰岛素输送设备以确保患者便利。胰岛素输送和监测系统（包括连续血糖监测仪和智慧胰岛素笔）的持续技术创新为市场创造有利的成长机会。透过更轻鬆地存取这些解决方案，医疗保健专业人员可以根据患者的个别需求和便利性客製化胰岛素管理方案，改善治疗结果。此外，该公司投资新技术，以提高患者便利性并满足对新设备和解决方案不断成长的需求。

本报告研究了全球胰岛素输送设备市场，并提供了市场概述，包括依产品、最终用户、地区划分的趋势和参与市场的公司概况。

目录

第1章 专案范围与定义

第2章 研究方法

第3章 执行摘要

第4章 2017-2031年全球胰岛素输送设备市场前景

• 市场规模分析与预测
• 市占率分析与预测
• 2023年市场地图分析
  • 依产品
  • 依最终用户
  • 依地区

第5章 北美胰岛素输送设备市场前景，2017-2031

第6章 欧洲胰岛素输送装置市场前景，2017-2031

第7章 亚太地区胰岛素输送设备市场展望，2017-2031年

第8章 南美洲胰岛素输送装置市场前景，2017-2031

第9章 中东与非洲胰岛素输送设备市场前景，2017-2031年

第10章 供需分析

第11章 进出口分析

第12章 价值链分析

第13章 波特五力分析

第14章 PESTLE分析

第15章 价格分析

第16章 市场动态

第17章 市场趋势与发展

第18章 监理架构与创新

第19章 专利状况

第20章 个案研究

第21章 竞争态势

• 前 5 名市场领导者的竞争矩阵
• 前 5 名参与公司的 SWOT 分析
• 市场前10位主要参与者的情况
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Becton, Dickinson and Company
  • Biocon
  • Owen Mumford Limited
  • Medtronic Plc
  • Tandem Diabetes Care, Inc.
  • Insulet Corporation
  • Ypsomed AG
  • Sanofi

第22章 策略建议

第23章 查询及免责声明

Global insulin delivery devices market is projected to witness a CAGR of 7.70% during the forecast period 2024-2031, growing from USD 22.12 billion in 2023 to USD 40.04 billion in 2031. The growth of the market is supported by the rising prevalence of diabetes, novel product launches, increasing government initiatives, and collaborations by the key players of the market. Insulin delivery devices, including insulin pens, pumps, needles, and syringes, are used to administer insulin to patients suffering from diabetes, allowing them to maintain optimum blood glucose levels.

Various healthcare and government organizations are working towards increasing awareness about diabetes and about the various devices available for the effective management of blood glucose levels. This increasing awareness encourages individuals to get routine checkups and adopt efficient insulin management solutions, fueling the market's expansion. It also encourages healthcare and medical device manufacturing companies to ensure the provision of advanced insulin delivery solutions through research and development and mergers and acquisitions. In September 2023, Abbott Laboratories acquired Bigfoot Biomedical Inc. to support the development of connected and personalized solutions for patients with diabetes. Bigfoot Unity, developed by Bigfoot Biomedical, provides reliable insulin dosage recommendations that are provided by the FDA-cleared connected insulin pen caps that it features. With this acquisition, the companies aim to bring together their individual expertise in diabetes care, which includes insulin injection support and continuous glucose monitoring, and provide high-quality products to their patients.

Rising Prevalence of Diabetes Supports Market Expansion

The rising cases of diabetes in various regions across the globe are boosting the global insulin delivery devices market size. According to the estimates of the World Health Organization (WHO), approximately 422 million individuals across the globe have diabetes. The rising number of diabetic patients is propelling the requirement for efficient insulin delivery devices, and increasing initiatives to bolster public awareness about the disease are contributing to a higher rate of diabetes checkups. Effective management of insulin levels is essential for managing diabetes because healthcare providers are ensuring that they provide a wide range of insulin delivery devices to ensure patient convenience. Continuous innovations in insulin delivery and monitoring systems, including continuous glucose monitors and smart insulin pens, are providing lucrative growth opportunities to the market. The increasing accessibility to these solutions allows healthcare professionals to customize insulin management regimes as per the requirements and convenience of individual patients, improving treatment outcomes. Various companies are also investing in novel technologies to enhance patient convenience and to meet the growing demand for novel devices and solutions. In March 2024, the twiist automated insulin delivery system by DEKA Research & Development Corp., received 510(k) clearance from the Food and Drug Administration (FDA). The device significantly improves insulin management for individuals with Type 1 diabetes. The company aims to distribute twiist through pharmacy channels so that individuals with type 1 diabetes can get an automated insulin delivery system in an affordable and convenient manner.

Technological Advancements Boost Market Growth

Rising investments in diabetes care due to the growing prevalence of the disease and increasing awareness are positively influencing the growth of the insulin delivery devices market. Due to increasing levels of income and growing health consciousness, diabetic patients are heavily investing in their health, which in turn is propelling the requirement for technologically advanced devices to ensure optimal insulin delivery.

Therefore, the key market players are actively investing in the development of novel solutions through research and development. In a significant development, in July 2024, CeQur SA announced that they had received 510(k) clearance from the FDA for 'Simplicity' for extended wearing duration. This clearance underscores the credibility of the disposable, wearable bolus insulin delivery system, which was developed as a wearable insulin pen and was launched in early 2021. In April 2021, CeQur SA raised USD 115 million for scaling up manufacturing and supporting the launch of the system. Insulin Pens are Expected to Hold a Significant Share of the Market

The demand for insulin pens is expected to increase significantly over the forecast period due to their ability to ensure accurate insulin administration. The rising utilization of insulin pens is also an indicator of the growing awareness among patients about the importance of insulin management for diabetes. This rise in awareness is also propelling patients to try different insulin delivery and management devices to gauge their merits and demerits and select the device most suitable to their individual requirements, supporting the expansion of the market. Furthermore, the market's key players are increasingly investing in introducing new products, boosting the segment's growth. For instance, in November 2022, Eli Lilly and Company rolled out the Tempo Personalized Diabetes Management Platform, comprising an insulin pen and a compatible app that work together to deliver personalized guidance for patients with diabetes.

North America Holds Significant Market Share

The market's expansion in the region is supported by the strong presence of key players, novel product launches, increasing cases of obesity, growing geriatric population, rising initiatives by the regional governments to combat diabetes, and high acceptance of new technologies. Additionally, the governments in the region are also taking various measures and introducing initiatives to boost awareness about the disease and take effective steps to combat it. In Canada, the 'Small Step for Big Changes' program was developed as a time-efficient and cost-effective program to reduce the risk of type 2 diabetes and is currently delivered at some YMCAs in British Columbia and is expected to be available at over 40 locations in 8 provinces across Canada by the end of 2025. The program is funded by the Canadian Institute of Health Research, allowing them to provide access to the participants to the YMCA and sessions with YMCA coaches to discuss physical activities and nutrition essential for the management of diabetes at no cost to the participant. According to the estimates of the Canadian Diabetes Association, over 5.7 million Canadians were living with diabetes in 2022.

Future Market Scenario (2024-2031F)

According to the global insulin delivery devices market analysis, the demand for insulin delivery devices is expected to increase significantly over the coming years due to rising cases of diabetes. As per the projections of the International Diabetes Federation (IDF), approximately 783 million individuals around the globe will be living with diabetes by 2045. Furthermore, the growing awareness about the various advantages associated with advanced insulin delivery systems, including enhanced safety, accuracy, and convenience, is also expected to boost the demand for global insulin delivery devices in the coming years.

Moreover, the key players in the market are actively investing in research and development activities and introducing novel technologies, and the government and healthcare organizations are taking measures to increase public awareness, fueling the market's expansion.

Key Players Landscape and Outlook

The global insulin delivery devices market growth is supported by the rising investments by the key players of the market towards the development of novel technologies and systems. In February 2024, Tandem Diabetes Care, Inc. announced the launch of their water-resistant Tandem Mobi insulin delivery system in the United States. The Tandem Mobi is the smallest automated insulin delivery system and leverages the company's Control-IQ technology that has been approved for usage by individuals who have type 1 diabetes and are age six and above. The system showed improvement in the time range in both night and day in several real-world studies and clinical trials and can be worn by patients with the help of a lightweight adhesive sleeve or can simply be slipped into the pocket. The device also incorporates advanced technologies, such as the capability for remote software updates and wireless charging. Such developments and introductions are expected to provide lucrative growth opportunities for the market in the coming years.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Insulin Delivery Devices Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Insulin Pumps
      • 4.2.1.1.1. Tethered Insulin Pumps
      • 4.2.1.1.2. Tubeless Insulin Pumps
    • 4.2.1.2. Insulin Pens
      • 4.2.1.2.1. Disposable Insulin Pens
      • 4.2.1.2.2. Reusable Insulin Pens
    • 4.2.1.3. Insulin Pen Needles
      • 4.2.1.3.1. Standard Insulin Pen Needles
      • 4.2.1.3.2. Safety Insulin Pen Needles
    • 4.2.1.4. Insulin Syringes
    • 4.2.1.5. Others
  • 4.2.2. By End-user
    • 4.2.2.1. Hospitals and Clinics
    • 4.2.2.2. Homecare Settings
    • 4.2.2.3. Others
  • 4.2.3. By Region
    • 4.2.3.1. North America
    • 4.2.3.2. Europe
    • 4.2.3.3. Asia-Pacific
    • 4.2.3.4. South America
    • 4.2.3.5. Middle East and Africa
  • 4.2.4. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Product
  • 4.3.2. By End-user
  • 4.3.3. By Region

5. North America Insulin Delivery Devices Market Outlook, 2017-2031F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. Insulin Pumps
      • 5.2.1.1.1. Tethered Insulin Pumps
      • 5.2.1.1.2. Tubeless Insulin Pumps
    • 5.2.1.2. Insulin Pens
      • 5.2.1.2.1. Disposable Insulin Pens
      • 5.2.1.2.2. Reusable Insulin Pens
    • 5.2.1.3. Insulin Pen Needles
      • 5.2.1.3.1. Standard Insulin Pen Needles
      • 5.2.1.3.2. Safety Insulin Pen Needles
    • 5.2.1.4. Insulin Syringes
    • 5.2.1.5. Others
  • 5.2.2. By End-user
    • 5.2.2.1. Hospitals and Clinics
    • 5.2.2.2. Homecare Settings
    • 5.2.2.3. Others
  • 5.2.3. By Country Share
    • 5.2.3.1. United States
    • 5.2.3.2. Canada
    • 5.2.3.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Insulin Delivery Devices Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
      • 5.3.1.1.2. By Volume
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Product
        • 5.3.1.2.1.1. Insulin Pumps
        • 5.3.1.2.1.1.1. Tethered Insulin Pumps
        • 5.3.1.2.1.1.2. Tubeless Insulin Pumps
        • 5.3.1.2.1.2. Insulin Pens
        • 5.3.1.2.1.2.1. Disposable Insulin Pens
        • 5.3.1.2.1.2.2. Reusable Insulin Pens
        • 5.3.1.2.1.3. Insulin Pen Needles
        • 5.3.1.2.1.3.1. Standard Insulin Pen Needles
        • 5.3.1.2.1.3.2. Safety Insulin Pen Needles
        • 5.3.1.2.1.4. Insulin Syringes
        • 5.3.1.2.1.5. Others
      • 5.3.1.2.2. By End-user
        • 5.3.1.2.2.1. Hospitals and Clinics
        • 5.3.1.2.2.2. Homecare Settings
        • 5.3.1.2.2.3. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Insulin Delivery Devices Market Outlook, 2017-2031F

• 6.1.1. Germany
• 6.1.2. France
• 6.1.3. Italy
• 6.1.4. United Kingdom
• 6.1.5. Russia
• 6.1.6. Netherlands
• 6.1.7. Spain
• 6.1.8. Poland

7. Asia-Pacific Insulin Delivery Devices Market Outlook, 2017-2031F

• 7.1.1. India
• 7.1.2. China
• 7.1.3. Japan
• 7.1.4. Australia
• 7.1.5. Vietnam
• 7.1.6. South Korea
• 7.1.7. Indonesia
• 7.1.8. Philippines

8. South America Insulin Delivery Devices Market Outlook, 2017-2031F

• 8.1.1. Brazil
• 8.1.2. Argentina

9. Middle East and Africa Insulin Delivery Devices Market Outlook, 2017-2031F

• 9.1.1. Saudi Arabia
• 9.1.2. UAE
• 9.1.3. South Africa
• 9.1.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

• 16.1. Market Drivers
• 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

• 18.1. Clinical Trials
• 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

• 21.1. Competition Matrix of Top 5 Market Leaders
• 21.2. SWOT Analysis for Top 5 Players
• 21.3. Key Players Landscape for Top 10 Market Players
  • 21.3.1. Novo Nordisk A/S
    • 21.3.1.1. Company Details
    • 21.3.1.2. Key Management Personnel
    • 21.3.1.3. Products and Services
    • 21.3.1.4. Financials (As Reported)
    • 21.3.1.5. Key Market Focus and Geographical Presence
    • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 21.3.2. Eli Lilly and Company
  • 21.3.3. Becton, Dickinson and Company
  • 21.3.4. Biocon
  • 21.3.5. Owen Mumford Limited
  • 21.3.6. Medtronic Plc
  • 21.3.7. Tandem Diabetes Care, Inc.
  • 21.3.8. Insulet Corporation
  • 21.3.9. Ypsomed AG
  • 21.3.10. Sanofi

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 2. Global Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 3. Global Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 4. Global Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 5. Global Insulin Delivery Devices Market Share (%), By Region, 2017-2031F
• Figure 6. North America Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 7. North America Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 8. North America Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 9. North America Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 10. North America Insulin Delivery Devices Market Share (%), By Country, 2017-2031F
• Figure 11. United States Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 12. United States Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 13. United States Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 14. United States Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 15. Canada Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 16. Canada Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 17. Canada Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 18. Canada Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 19. Mexico Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 20. Mexico Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 21. Mexico Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 22. Mexico Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 23. Europe Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 24. Europe Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 25. Europe Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 26. Europe Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 27. Europe Insulin Delivery Devices Market Share (%), By Country, 2017-2031F
• Figure 28. Germany Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 29. Germany Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 30. Germany Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 31. Germany Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 32. France Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 33. France Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 34. France Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 35. France Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 36. Italy Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 37. Italy Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 38. Italy Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 39. Italy Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 40. United Kingdom Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 41. United Kingdom Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 42. United Kingdom Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 43. United Kingdom Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 44. Russia Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 45. Russia Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 46. Russia Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 47. Russia Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 48. Netherlands Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 49. Netherlands Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 50. Netherlands Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 51. Netherlands Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 52. Spain Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 53. Spain Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 54. Spain Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 55. Spain Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 56. Turkey Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 57. Turkey Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 58. Turkey Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 59. Turkey Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 60. Poland Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 61. Poland Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 62. Poland Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 63. Poland Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 64. South America Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 65. South America Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 66. South America Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 67. South America Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 68. South America Insulin Delivery Devices Market Share (%), By Country, 2017-2031F
• Figure 69. Brazil Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 70. Brazil Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 71. Brazil Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 72. Brazil Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 73. Argentina Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 74. Argentina Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 75. Argentina Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 76. Argentina Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 77. Asia-Pacific Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 78. Asia-Pacific Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 79. Asia-Pacific Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 80. Asia-Pacific Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 81. Asia-Pacific Insulin Delivery Devices Market Share (%), By Country, 2017-2031F
• Figure 82. India Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 83. India Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 84. India Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 85. India Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 86. China Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 87. China Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 88. China Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 89. China Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 90. Japan Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 91. Japan Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 92. Japan Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 93. Japan Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 94. Australia Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 95. Australia Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 96. Australia Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 97. Australia Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 98. Vietnam Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 99. Vietnam Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 100. Vietnam Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 101. Vietnam Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 102. South Korea Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 103. South Korea Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 104. South Korea Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 105. South Korea Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 106. Indonesia Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 107. Indonesia Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 108. Indonesia Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 109. Indonesia Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 110. Philippines Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 111. Philippines Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 112. Philippines Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 113. Philippines Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 114. Middle East & Africa Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 115. Middle East & Africa Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 116. Middle East & Africa Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 117. Middle East & Africa Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 118. Middle East & Africa Insulin Delivery Devices Market Share (%), By Country, 2017-2031F
• Figure 119. Saudi Arabia Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 120. Saudi Arabia Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 121. Saudi Arabia Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 122. Saudi Arabia Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 123. UAE Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 124. UAE Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 125. UAE Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 126. UAE Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 127. South Africa Insulin Delivery Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 128. South Africa Insulin Delivery Devices Market, By Volume, in Units, 2017-2031F
• Figure 129. South Africa Insulin Delivery Devices Market Share (%), By Product, 2017-2031F
• Figure 130. South Africa Insulin Delivery Devices Market Share (%), By End-user, 2017-2031F
• Figure 131. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 132. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 133. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023